Abstract
Background and objectives
Despite recent increases in crystal methamphetamine use among high-risk populations such as street-involved youth, few prospective studies have examined the health and social outcomes associated with active crystal methamphetamine use.
Methods
We enrolled 1,019 street-involved youth in Vancouver, Canada, in a prospective cohort known as the At-Risk Youth Study (ARYS). Participants were assessed semi-annually and a generalized estimating equation (GEE) logistic regression was used to identify factors independently associated with active crystal methamphetamine use.
Results
Among 1,019 participants recruited into ARYS between 2005 and 2012 the median follow up duration was 17 months, 320 (31.4%) participants were female and 454 (44.6%) had previously used crystal methamphetamine at baseline. In adjusted GEE analyses, active crystal methamphetamine use was independently associated with Caucasian ethnicity (Adjusted Odds Ratio [AOR] = 1.37; 95% Confidence Interval [CI]: 1.04 – 1.81), homelessness (AOR = 1.34; 95% CI: 1.15 – 1.56), injection drug use (AOR = 3.40; 95% CI: 2.76 – 4.19), non-fatal overdose (AOR = 1.46; 95% CI: 1.07 – 2.00), being a victim of violence (AOR = 1.19; 95% CI: 1.02 – 1.38), involvement in sex work (AOR = 1.39; 95% CI: 1.03 – 1.86) and drug dealing (AOR = 1.60; 95% CI: 1.35 – 1.90).
Discussion and conclusions
Prevalence of crystal methamphetamine use was high in this setting and active use was independently associated with a range of serious health and social harms.
Scientific Significance
Evidence-based strategies to prevent and treat crystal methamphetamine use are urgently needed.
Keywords: crystal methamphetamin, youth, injection drug use, social harm, homelessness
INTRODUCTION
Past studies have shown that illicit drug use is common among street-involved youth1–3 and has been associated with a range of health and social harms including spread of infectious diseases, drug overdose, risky sexual practices and confrontations with police.4–8 Street-involved youth may be particularly susceptible to the health and social harms of illicit drug use given their marginalized position, low socioeconomic status and poor access to health care services.9 In recent years, reports have revealed a high prevalence of crystal methamphetamine use among street-involved youth,10 mirroring a global trend that puts amphetamine-type stimulants as the second most widely used illicit drug in the world, following cannabis.11 Methamphetamine is manufactured from common, easily obtainable precursor chemicals12 and is synthesized in small-scale, local “meth labs”. As such, it widely available and easily to obtain on the street level.13
Crystal methamphetamine is a highly potent form of methamphetamine and is more commonly injected than other forms of methamphetamine, resulting in higher addiction potential and blood borne disease transmission.14 Existing evidence indicates that crystal methamphetamine use may be associated with high-risk sexual and drug use activities, although the majority of this data is from studies of gay men and adult drug users.15–23 For example, crystal methamphetamine use has been associated with unprotected anal intercourse in HIV positive men,20 unprotected anal intercourse with casual partners 23 and having multiple sexual partners.21, 22 In terms of high-risk drug activities, crystal methamphetamine use has been associated with injection drug use,10 and syringe borrowing and lending.15 Other health and social harms associated with crystal methamphetamine use include incarceration, trading sex for money and alcohol and cigarette consumption.8, 24
Despite the recognition of increasing crystal methamphetamine use among young people, few prospective studies have examined health and social outcomes associated with active crystal methamphetamine use in longitudinal analyses. Therefore, we took advantage of a large, longitudinal prospective cohort of street-involved youth to examine the distinct health and social harms associated with active crystal methamphetamine use in this population.
METHODS
The At-Risk Youth Study (ARYS) is a prospective cohort study of Vancouver street-involved youth that has been described in detail previously.25 In brief, snowball sampling and extensive street-based outreach methods were utilized. Eligibility for the study included age 14 to 26 years at baseline, use of illicit drugs other than marijuana in the past 30 days, and street-involved, defined as being absolutely or temporarily without stable housing, or having accessed street-based youth services in past six months. Similar conditions have previously been used to define street-involvement among youth 26, 27. At baseline and every six months thereafter, participants completed an interviewer-administered questionnaire pertaining to socio-demographic information, sex- and drug-related risk behaviors including specific drugs used and modes of use. At every visit, participants also provided blood samples in order to ascertain HIV and hepatitis C (HCV) infection status and received $20 CAD as remuneration. ARYS was ethically approved by the Research Ethics Board of the University of British Columbia. For the present analyses, all individuals who were recruited between September 2005 and May 2012 were included.
In order to address the present study’s aims, we compared those youth who reported using crystal methamphetamine in the past six months to those who did not (ie. past users or never users). Covariates were selected a priori based on their known or hypothesized relationship with the primary outcome. Demographic variables considered as potentially associated with active crystal methamphetamine use included gender (female vs. male) and ethnicity (Caucasian vs. other). Social and behavior variables included homelessness (yes vs. no); injection drug use (yes vs. no); daily marijuana use (yes vs. no); cocaine use (yes vs. no); crack cocaine smoking (yes vs. no); heroin use (yes vs. no); requiring help injecting (yes vs. no); borrowing or sharing syringes (yes vs. no); any injection of drugs in public (yes vs. no); unsafe sex (defined as vaginal or anal penetration without a condom (yes vs. no)); being a victim of violence (yes vs. no); having a police encounter (defined as having been stopped, searched or detained by police (yes vs. no)); incarceration (defined as being in detention, prison, or jail overnight or longer (yes vs. no)); involvement in sex work (defined as exchanging sex for money, gifts, food, shelter, clothes, drugs or other (yes vs. no)); and drug dealing (yes vs. no). All social and behavioural variables refer to the six-month period prior to the interview. Health-related variables included non-fatal overdose in the past six months (yes vs. no), hepatitis C positivity (yes vs. no) and HIV positivity (yes vs. no). All variable definitions have been used extensively and were identical to earlier publications.28,29
Although no explicit inclusion criterion required that youth spend a minimum amount of time on the street or actually live on the street to qualify for the study, in practice, the street-based recruitment produced a sample of youth who spent extensive time on the street, a large proportion of whom were homeless (defined as having no secure place to sleep). Still, because our study lacked an explicit requirement that youth live on the street, we use throughout the present manuscript the term “street-involved youth” rather than “street youth”, since the latter of these terms is generally applied to youth known to live full-time or part-time on the street.
Initially, we compared covariates of interest at baseline stratified by baseline crystal methamphetamine use in the past six months using Pearson’s Chi-square test (dichotomous variables) and the Wilcoxon rank test (continuous variables). Then, since serial measures for cohort participants were available, variables potentially associated with active crystal methamphetamine use during each follow-up were evaluated using generalized estimating equations (GEE) with logit link for binary outcomes. This enabled us to examine variables associated with reporting crystal methamphetamine use during the entire study period.
As a first step, bivariate GEE analyses were used to determine potential factors associated with active crystal methamphetamine use. We then fit a multivariate model where all variables that had a p value ≤ 0.10 in GEE bivariate analyses were considered in a full model. Variable selection for the final model was done using the Quasilikelihood under the Independence model Criterion (QIC) statistic with a backward model selection procedure.30 All possible combinations of candidate variables were screened to identify the model with the best overall fit as indicated by the lowest QIC value. These methods provide standard errors adjusted by multiple observations per person using an exchangeable correlation structure. Therefore, data from every participant follow-up visit was considered in this analysis. This approach serves to examine behaviors and characteristics that correlated with times when a participant used crystal methamphetamine within individuals and between individuals. All statistical analyses were performed using SAS software version 9.3 (SAS, Cary, NC, USA). All p-values are two sided.
RESULTS
Between September 2005 and May 2012, 1,019 street youth were recruited into the ARYS cohort. Among these individuals, the median age was 22 (inter-quartile range [IQR]: 20 – 24), 320 (31.4%) were female, and 686 (67.3%) were Caucasian. This sample contributed a total of 3347 observations. The median follow up duration was 17 months.
Among the 1,019 participants recruited into ARYS, 704 (69.0%) reported a history of crystal methamphetamine use at baseline and 454 (44.5%) reported using crystal methamphetamine in the 6 months prior to baseline interview. As shown in Table 1, socio-demographic and behavioural characteristics associated with prior use of crystal methamphetamine at baseline included: Caucasian ethnicity, homelessness, drug injecting, crack cocaine smoking, heroin use, non-fatal overdose, requiring help injecting, syringe sharing, public injection, hepatitis C positivity, police encounters, involvement in sex work, and drug dealing (all p < 0.05). Gender, daily marijuana use, cocaine use, HIV positivity, unsafe sex, being a victim of violence and incarceration were not associated with prior crystal methamphetamine use.
TABLE 1.
Characteristic | Total (%) (n = 1019) |
Crystal methamphetamine use |
p-value | |
---|---|---|---|---|
No (%) (n = 565) |
Yes (%) (n = 454) |
|||
Female | 320 (31.4) | 173 (30.6) | 147 (32.4) | 0.528 |
Caucasian | 686 (67.3) | 350 (62.0) | 336 (74.0) | <0.001 |
Homelessness† | 743 (72.9) | 391 (69.2) | 352 (77.5) | 0.002 |
Injection drug use | 299 (29.3) | 101 (17.9) | 198 (43.6) | <0.001 |
Daily marijuana use | 496 (48.7) | 275 (48.7) | 221 (48.7) | 0.848 |
Cocaine use | 502 (49.3) | 283 (50.1) | 219 (48.2) | 0.484 |
Crack cocaine smoking | 603 (59.2) | 303 (53.6) | 300 (66.1) | <0.001 |
Heroin use | 345 (33.9) | 142 (25.1) | 203 (44.7) | <0.001 |
Non-fatal overdose | 112 (11.0) | 45 (8.0) | 67 (14.8) | <0.001 |
Requiring help injecting | 94 (9.2) | 32 (5.7) | 62 (13.7) | <0.001 |
Syringe sharing | 83 (8.2) | 28 (5.0) | 55 (12.1) | <0.001 |
Public injection | 223 (21.9) | 73 (12.9) | 150 (33.0) | <0.001 |
Hepatitis C positive | 104 (10.2) | 46 (8.1) | 58 (12.8) | 0.017 |
HIV positive | 10 (0.98) | 6 (1.1) | 4 (0.88) | 1.000 |
Unsafe sex | 567 (55.6) | 304 (53.8) | 263 (57.9) | 0.292 |
Victim of violence | 454 (44.6) | 243 (43.0) | 211 (46.5) | 0.344 |
Police encounter | 346 (34.0) | 173 (30.6) | 173 (38.1) | 0.013 |
Incarceration | 189 (18.6) | 106 (18.8) | 83 (18.3) | 0.776 |
Sex work | 101 (9.91) | 43 (7.6) | 58 (12.8) | 0.006 |
Drug dealing | 538 (52.8) | 275 (48.7) | 263 (57.9) | 0.003 |
All behavioral variables refer to activities during the past six months.
There are no missing data points.
Over the study period, 38.6% (n=1292) of observations included a report of active crystal methamphetamine use. Among 205 individuals who had not reported crystal methamphetamine use at baseline and had at least one follow up visit, 46 (22.4%) reported crystal methamphetamine use at some point during follow-up for an incidence density of 12.2 per 100 person-years. As there was heterogeneity in the number and times of follow-up visits, it was not possible to categorize participants as steady or short-term users of crystal methamphetamine.
The results of the bivariate and multivariate GEE analyses are presented in Table 2. In the multivariate GEE model, factors that were independently associated with active crystal methamphetamine use included: Caucasian ethnicity (Adjusted Odds Ratio [AOR] = 1.37 [95% Confidence Interval [CI]: 1.04 – 1.81]); homelessness (AOR = 1.34 [95% CI: 1.15 – 1.56); injection drug use (AOR = 3.40 [95% CI: 2.76 – 4.19); non-fatal overdose (AOR = 1.46 [95%CI: 1.07 – 2.00]); being a victim of violence (AOR = 1.19 [95% CI: 1.02 – 1.38]); involvement in sex work (AOR = 1.39 [95% CI: 1.03 – 1.86]); and drug dealing (AOR = 1.60 [95% CI: 1.35 – 1.90]).
Table 2.
Unadjusted |
Adjusted |
|||
---|---|---|---|---|
Characteristic | Odds Ratio (95% CI) |
p-value | Odds Ratio (95% CI) |
p-value |
Female | ||||
(yes vs. no) | 0.90 (0.71 – 1.13) | 0.367 | ||
Caucasian | ||||
(yes vs. no) | 1.54 (1.20 – 1.96) | 0.001 | 1.37 (1.04 – 1.81) | 0.026 |
Homelessness† | ||||
(yes vs. no) | 1.47 (1.29 – 1.68) | <0.001 | 1.34 (1.15 – 1.56) | <0.001 |
Injection drug use | ||||
(yes vs. no) | 3.60 (2.99 – 4.33) | <0.001 | 3.40 (2.76 – 4.19) | <0.001 |
Daily marijuana use | ||||
(yes vs. no) | 1.08 (0.93 – 1.26) | 0.289 | ||
Cocaine use | ||||
(yes vs. no) | 1.31 (1.14 – 1.50) | 0.001 | ||
Crack cocaine smoking | ||||
(yes vs. no) | 1.51 (1.29 –1.76) | <0.001 | ||
Heroin use | ||||
(yes vs. no) | 2.10 (1.76 – 2.50) | <0.001 | ||
Non-fatal overdose | ||||
(yes vs. no) | 1.94 (1.53 – 2.45) | <0.001 | 1.46 (1.07 – 2.00) | 0.017 |
Requiring help injecting | ||||
(yes vs. no) | 2.38 (1.89 – 3.00) | <0.001 | ||
Syringe sharing | ||||
(yes vs. no) | 2.25 (1.69 – 3.00) | <0.001 | ||
Public injection | ||||
(yes vs. no) | 2.30 (1.89 – 2.80) | <0.001 | ||
Hepatitis C positive | ||||
(yes vs. no) | 1.17 (0.91 – 1.50) | 0.219 | ||
HIV positive | ||||
(yes vs. no) | 0.99 (0.35 – 2.78) | 0.981 | ||
Unsafe sex | ||||
(yes vs. no) | 1.20 (1.06 – 1.37) | 0.006 | 1.13 (0.96 – 1.33) | 0.140 |
Victim of violence | ||||
(yes vs. no) | 1.31 (1.15 – 1.48) | <0.001 | 1.19 (1.02 – 1.38) | 0.022 |
Police encounter | ||||
(yes vs. no) | 1.41 (1.24 – 1.62) | <0.001 | ||
Incarceration | ||||
(yes vs. no) | 1.17 (1.00 – 1.37) | 0.048 | ||
Sex work | ||||
(yes vs. no) | 1.87 (1.45 – 2.41) | <0.001 | 1.39 (1.03 – 1.86) | 0.030 |
Drug dealing | ||||
(yes vs. no) | 1.89 (1.65 – 1.17) | <0.001 | 1.60 (1.35 – 1.90) | <0.001 |
All behavioral variables refer to activities during the past six months.
DISCUSSION
In the present study, we found a high prevalence of crystal methamphetamine use among street-involved youth upon recruitment into the study and found that Caucasian ethnicity, homelessness, injection drug use, non-fatal overdoses, being a victim of violence, involvement in sex work and drug dealing were independently associated with active crystal methamphetamine use over study follow-up. In our study, 69% of participants reported a prior history of crystal methamphetamine use. This is much higher than the 6.6% reported in non-injection drug using Canadian street youth, 31 or the 2.8% reported in a large, cross-sectional analysis of American youth.32
To our knowledge, this is the first study to show prospectively that active crystal methamphetamine use is associated with injection drug use in street-involved youth. Given the known harms of injection drug use, this finding has important public health implications. As the popularity of crystal methamphetamine use has increased worldwide,11,33 the association with injection drug use has important implications for infectious disease transmission and efforts to prevent initiation in to injecting.34 As people who inject methamphetamine are more likely to engage in risky injection practices than users of other injection drugs,35 the risk of disease transmission is even more concerning. Although several safer injecting programs exist in the study locale (Vancouver, Canada) resulting in decreasing rates of HCV and HIV in injection drug users,36 global coverage of recommended HIV prevention interventions for drug users remains low.14 In a previous analysis, our study population was found to have high rates of injection drug use with 41.1% of participants reporting previous use.29 This is similar to a study of street youth in Montreal in which 44% of participants had a history of injection drug use,37 but slightly more than the 28% prevalence of injection drug users in a cohort of Los Angeles based street-involved youth.8 It is likely that these populations represent groups of youth who participate in high-risk activities including illicit drug use.
To our knowledge, this is also the first study to show longitudinally that homelessness is associated with active crystal methamphetamine use in street-involved youth after adjustment for a range of confounders, including other drug use patterns. One possible link between homelessness and active crystal methamphetamine use is that street-involved youth use the drug in part to stay alert while sleeping on the street.38 Our findings are similar to a longitudinal analysis of adult injection drug users, which found that homelessness was associated with initiating methamphetamine injection.39 As well, Coady et al. found in cross sectional analysis that at least daily methamphetamine use was associated with homelessness.40 Future research should seek to unpack the relationship between active crystal methamphetamine use and homelessness to determine the whether active crystal methamphetamine use results in instability that leads to homelessness or whether crystal methamphetamine is simply a drug of choice among homeless individuals.
In addition, the present study found that active use of crystal methamphetamine was associated with a range of other health and social harms including non-fatal overdose, being a victim of violence, involvement in sex work and drug dealing. Together these findings are consistent with studies of methamphetamine use in other populations,41 and point to a very broad set of risks associated with active crystal methamphetamine use. These findings highlight the urgent need to identify prevention and treatment strategies that seek to reduce crystal methamphetamine use, as well as participation in high-risk activities among crystal methamphetamine users.42 Importantly, studies have shown that criminal justice measures aimed at reducing methamphetamine use have been largely ineffective and financially costly.13,42 These findings suggest that public health and addiction treatment measures to compliment law enforcement efforts are required.
This study has several limitations. As there are no voters’ lists or other registries from which to draw a random sample, caution is required when interpreting our results to other populations of street youth. However, it is noteworthy that the cohort demographics are similar to other local and international studies of street-involved youth.6,43 Second, there is a concern of socially desirable responding in studies of marginalized populations.44 With respect to this concern, we know of no reason why risk behaviors would be differentially reported between crystal methamphetamine users and non-users. Nevertheless, although confidentiality is assured as part of the interview and interviewers are trained to build trust and rapport with the participants it is possible we underestimated some behaviors in the present study.
Since this is an observational study, there is always the potential for residual confounding. For instance, youth using crystal methamphetamine may carry other personal characteristics (e.g. mental health concerns) or genetic predisposition to high intensity drug use, neither of which were measured in the present study. Nevertheless, our study clearly demonstrates health and social harms associated with crystal methamphetamine use.
While our analyses explored correlates of crystal methamphetamine use and many participants transitioned in and out of using crystal methamphetamine during the study period, our analyses did not specifically explore potential health benefits of reducing or eliminating crystal methamphetamine use or specific health concerns experienced when crystal methamphetamine use is first initiated. Future studies should explore these issues and, in particular, the role of crystal methamphetamine treatment in reducing the harms of crystal methamphetamine use.
In summary, the present study found a high prevalence of active crystal methamphetamine use among street-involved youth and that this behavior measured longitudinally was associated with Caucasian ethnicity, homelessness, injection drug use, non-fatal overdoses, being a victim of violence, involvement in sex work and drug dealing. These findings highlight the urgent need for novel evidence-based prevention and treatment initiatives for crystal methamphetamine use.
Acknowledgments
The study was supported by the US National Institutes of Health, Maryland, United States (R01-DA028532) and the Canadian Institutes of Health Research, Ottawa, Canada (MOP-102742). This research was undertaken, in part, thanks to funding from the Canada Research Chairs program through a Tier 1 Canada Research Chair in Inner City Medicine, which supports Dr. Evan Wood. Dr. Kora DeBeck is supported by a MSFHR/St. Paul’s Hospital-Providence Health Care Career Scholar Award. Dr. Julio Montaner has received an Avant-Garde award (DP1DA026182) from the National Institute of Drug Abuse, US National Institutes of Health.
The authors thank the ARYS study participants for their contribution to the research, as well as current and past researchers and staff. We would specifically like to thank Cody Callon, Jennifer Matthews, Deborah Graham, Peter Vann, Steve Kain, Tricia Collingham, and Carmen Rock for their research and administrative assistance.
Footnotes
Declaration of Interest: Dr. Julio Montaner has received grants from, served as an ad hoc advisor to, or spoke at various events sponsored by; Abbott, Argos Therapeutics, Bioject Inc, Boehringer Ingelheim, BMS, Gilead Sciences, GlaxoSmithKline, Hoffmann-La Roche, Janssen-Ortho, Merck Frosst, Pfizer, Schering, Serono Inc, TheraTechnologies, Tibotec, Trimeris. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this paper.
REFERENCES
- 1.Martino SC, Tucker JS, Ryan G, Wenzel SL, Golinelli D, Munjas B. Increased substance use and risky sexual behavior among migratory homeless youth: exploring the role of social network composition. Journal of youth and adolescence. 2011;40:1634–1648. doi: 10.1007/s10964-011-9646-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Rosenthal D, Mallett S, Milburn N, Rotheram-Borus MJ. Drug use among homeless young people in Los Angeles and Melbourne. J Adolesc Health. 2008;43:296–305. doi: 10.1016/j.jadohealth.2008.06.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Hudson AL, Nandy K. Comparisons of substance abuse, high-risk sexual behavior and depressive symptoms among homeless youth with and without a history of foster care placement. Contemporary nurse. 2012;42:178–186. doi: 10.5172/conu.2012.42.2.178. [DOI] [PubMed] [Google Scholar]
- 4.Miller CL, Kerr T, Fischer B, Zhang R, Wood E. Methamphetamine injection independently predicts hepatitis C infection among street-involved youth in a Canadian setting. J Adolesc Health. 2009;44:302–304. doi: 10.1016/j.jadohealth.2008.08.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Molitor F, Truax SR, Ruiz JD, Sun RK. Association of methamphetamine use during sex with risky sexual behaviors and HIV infection among non-injection drug users. West J Med. 1998;168:93–97. [PMC free article] [PubMed] [Google Scholar]
- 6.Corsi KF, Kwiatkowski CF, Booth RE. Predictors of methamphetamine injection in out-of-treatment IDUs. Subst Use Misuse. 2009;44:332–342. doi: 10.1080/10826080802344765. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Ti L, Wood E, Shannon K, Feng C, Kerr T. Police confrontations among street-involved youth in a Canadian setting. Int J Drug Policy. 2013;24:46–51. doi: 10.1016/j.drugpo.2012.06.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Nyamathi A, Hudson A, Greengold B, Leake B. Characteristics of Homeless Youth Who Use Cocaine and Methamphetamine. Am J Addict. 2012;21:243–249. doi: 10.1111/j.1521-0391.2012.00233.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Kulik DM, Gaetz S, Crowe C, Ford-Jones EL. Homeless youth’s overwhelming health burden: A review of the literature. Paediatrics & child health. 2011;16:43–47. doi: 10.1093/pch/16.6.e43. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Wood E, Stoltz JA, Zhang R, Strathdee SA, Montaner JS, Kerr T. Circumstances of first crystal methamphetamine use and initiation of injection drug use among high-risk youth. Drug Alcohol Rev. 2008;27:270–276. doi: 10.1080/09595230801914750. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.UNODC. United Nations Office on Drugs and Crime: Recent Statistics and Trend Analysis of Illicit Drug Markets. 2012 [Google Scholar]
- 12.Lineberry TW, Bostwick JM. Methamphetamine abuse: a perfect storm of complications. Mayo Clinic proceedings Mayo Clinic. 2006;81:77–84. doi: 10.4065/81.1.77. [DOI] [PubMed] [Google Scholar]
- 13.Hadland SE, Marshall BD, Kerr T, Lai C, Montaner JS, Wood E. Ready access to illicit drugs among youth and adult users. Am J Addict. 2012;21:488–490. doi: 10.1111/j.1521-0391.2012.00257.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Mathers BM, Degenhardt LJ, Phillips B, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: A systematic review. Lancet. 2008;372:1733–1745. doi: 10.1016/S0140-6736(08)61311-2. [DOI] [PubMed] [Google Scholar]
- 15.Fairbairn N, Kerr T, Buxton JA, Li K, Montaner JS, Wood E. Increasing use and associated harms of crystal methamphetamine injection in a Canadian setting. Drug Alcohol Depend. 2007;88:313–316. doi: 10.1016/j.drugalcdep.2006.10.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Green AI, Halkitis PN. Crystal methamphetamine and sexual sociality in an urban gay subculture: an elective affinity. Cult Health Sex. 2006;8:317–333. doi: 10.1080/13691050600783320. [DOI] [PubMed] [Google Scholar]
- 17.Halkitis PN, Parsons JT, Stirratt MJ. A double epidemic: crystal methamphetamine drug use in relation to HIV transmission among gay men. J Homosex. 2001;41:17–35. doi: 10.1300/J082v41n02_02. [DOI] [PubMed] [Google Scholar]
- 18.Mansergh G, Colfax GN, Marks G, Rader M, Guzman R, Buchbinder S. The Circuit Party Men’s Health Survey: findings and implications for gay and bisexual men. Am J Public Health. 2001;91:953–958. doi: 10.2105/ajph.91.6.953. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Cheng WS, Garfein RS, Semple SJ, Strathdee SA, Zians JK, Patterson TL. Increased drug use and STI risk with injection drug use among HIV-seronegative heterosexual methamphetamine users. J Psychoactive Drugs. 2010;42:11–18. doi: 10.1080/02791072.2010.10399781. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Pantalone DW, Huh D, Nelson KM, Pearson CR, Simoni JM. Prospective Predictors of Unprotected Anal Intercourse Among HIV-Seropositive Men Who Have Sex with Men Initiating Antiretroviral Therapy. AIDS Behav. 2013 doi: 10.1007/s10461-013-0477-1. Epub ahead of print. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Garofalo R, Mustanski BS, McKirnan DJ, Herrick A, Donenberg GR. Methamphetamine and young men who have sex with men: understanding patterns and correlates of use and the association with HIV-related sexual risk. Arch Pediatr Adolesc Med. 2007;161:591–596. doi: 10.1001/archpedi.161.6.591. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Bonell CP, Hickson FC, Weatherburn P, Reid DS. Methamphetamine use among gay men across the UK. Int J Drug Policy. 2010;21:244–246. doi: 10.1016/j.drugpo.2009.07.002. [DOI] [PubMed] [Google Scholar]
- 23.Rawstorne P, Digiusto E, Worth H, Zablotska I. Associations between crystal methamphetamine use and potentially unsafe sexual activity among gay men in Australia. Archives of sexual behavior. 2007;36:646–654. doi: 10.1007/s10508-007-9206-z. [DOI] [PubMed] [Google Scholar]
- 24.Russell K, Dryden DM, Liang Y, et al. Risk factors for methamphetamine use in youth: a systematic review. BMC pediatrics. 2008;8:48. doi: 10.1186/1471-2431-8-48. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Wood E, Stoltz JA, Montaner JSG, Kerr T. Evaluating methamphetamine use and risks of injection initiation among street youth: the ARYS study. Harm Reduction Journal. 2006;3:18. doi: 10.1186/1477-7517-3-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Boivin JF, Roy E, Haley N, Galbaud du Fort G. The health of street youth: a Canadian perspective. Can J Public Health. 2005;96:432–437. doi: 10.1007/BF03405183. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.DeMatteo D, Major C, Block B, Coates R, Fearon M, Goldberg E, King SM, Millson M, O’Shaughnessy M, Read SE. Toronto street youth and HIV/AIDS: prevalence, demographics, and risks. J Adolesc Health. 1999 Nov;25(5):358–366. doi: 10.1016/s1054-139x(99)00059-2. [DOI] [PubMed] [Google Scholar]
- 28.Hadland SE, Marshall BD, Kerr T, Zhang R, Montaner JS, Wood E. A comparison of drug use and risk behavior profiles among younger and older street youth. Subst Use Misuse. 2011;46:1486–1494. doi: 10.3109/10826084.2011.561516. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Kerr T, Marshall BD, Miller C, et al. Injection drug use among street-involved youth in a Canadian setting. BMC Public Health. 2009;9:171. doi: 10.1186/1471-2458-9-171. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Cui J. QIC program and model selection in GEE analyses. Stata Journal. 2007;7:209–220. [Google Scholar]
- 31.PHAC. Canadian Street Youth and Substance Use: Findings from Enhanced. Surveillance of Canadian Street Youth, 1999 – 2003. 2007 [Google Scholar]
- 32.Iritani BJ, Hallfors DD, Bauer DJ. Crystal methamphetamine use among young adults in the USA. Addiction. 2007;102:1102–1113. doi: 10.1111/j.1360-0443.2007.01847.x. [DOI] [PubMed] [Google Scholar]
- 33.Vearrier D, Greenberg MI, Miller SN, Okaneku JT, Haggerty DA. Methamphetamine: history, pathophysiology, adverse health effects, current trends, and hazards associated with the clandestine manufacture of methamphetamine. Dis Mon. 2012;58:38–89. doi: 10.1016/j.disamonth.2011.09.004. [DOI] [PubMed] [Google Scholar]
- 34.Vlahov D, Fuller CM, Ompad DC, Galea S, Des Jarlais DC. Updating the Infection Risk Reduction Hierarchy: Preventing Transition into Injection. J Urban Health. 2004;81:14–19. doi: 10.1093/jurban/jth083. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Degenhardt L, Day C, Hall W. The causes, course and consequences of the heroin shortage in Australia. 2004 Online: http://www.ndlerf.gov.au/pub/Aust_exec.pdf.
- 36.Kerr T, Small W, Buchner C, et al. Syringe sharing and HIV incidence among injection drug users and increased access to sterile syringes. Am J Public Health. 2010;100:1449–1453. doi: 10.2105/AJPH.2009.178467. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Roy E, Boudreau JF, Leclerc P, Boivin JF, Godin G. Trends in injection drug use behaviors over 10 years among street youth. Drug Alcohol Depend. 2007;89:170–175. doi: 10.1016/j.drugalcdep.2006.12.025. [DOI] [PubMed] [Google Scholar]
- 38.Bungay V, Malchy L, Buxton JA, Johnson J, MacPherson D, Rosenfeld T. Life with jib: A snapshot of street youth’s use of crystal methamphetamine. Addiction Research & Theory. 2006;14:235–251. [Google Scholar]
- 39.Marshall BD, Wood E, Shoveller JA, Buxton JA, Montaner JS, Kerr T. Individual, social, and environmental factors associated with initiating methamphetamine injection: implications for drug use and HIV prevention strategies. Prev Sci. 2011;12:173–180. doi: 10.1007/s11121-010-0197-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Coady MH, Latka MH, Thiede H, et al. Housing status and associated differences in HIV risk behaviors among young injection drug users (IDUs) AIDS Behav. 2007;11:854–863. doi: 10.1007/s10461-007-9248-1. [DOI] [PubMed] [Google Scholar]
- 41.Fairbairn N, Wood E, Stoltz JA, Li K, Montaner J, Kerr T. Crystal methamphetamine use associated with non-fatal overdose among a cohort of injection drug users in Vancouver. Public Health. 2008;122:70–78. doi: 10.1016/j.puhe.2007.02.016. [DOI] [PubMed] [Google Scholar]
- 42.Colfax G, Santos GM, Chu P, et al. Amphetamine-group substances and HIV. Lancet. 2010;376:458–474. doi: 10.1016/S0140-6736(10)60753-2. [DOI] [PubMed] [Google Scholar]
- 43.Miller CL, Strathdee SA, Kerr T, Li K, Wood E. Factors associated with early adolescent initiation into injection drug use: implications for intervention programs. J Adolesc Health. 2006;38:462–464. doi: 10.1016/j.jadohealth.2005.03.004. [DOI] [PubMed] [Google Scholar]
- 44.Des Jarlais DC, Paone D, Milliken J, et al. Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial. Lancet. 1999;353:1657–1661. doi: 10.1016/s0140-6736(98)07026-3. [DOI] [PubMed] [Google Scholar]